Advertisement

Reulceration and Reoperation Rates After Central Ray Amputations: A Retrospective Study

Published:November 24, 2022DOI:https://doi.org/10.1053/j.jfas.2022.11.014

      Abstract

      Re-ulceration is a common complication following ray amputations of the foot. The primary aim of this study was to evaluate the incidence of re-ulceration following isolated and combined central ray amputations. This was a retrospective review of 55 consecutive limbs that underwent central ray amputations at Wake Forest Baptist Medical Centers (WFBMC). Procedures were performed at the three central rays or a combination of central rays. Incidence of postoperative ulceration was evaluated on the ipsilateral foot. We hypothesized there would not be an association between which ray was resected and development of reulceration. 24 patients (43%) experienced repeat ulceration following a central ray amputation. Median follow up time was 17.4 months (range 4 days to 99 months). The estimated ulcer recurrence rate at 1 year was 41.8%. There was no statistical difference based on location of amputation (second, third, four rays) with regards to reulceration, further amputation, transmetatarsal amputation, or below knee amputations. However, reulceration seemed to be much quicker in those patients undergoing a third ray amputation. Like the medial and lateral rays, central ray amputations can be a good initial salvage procedure to clear devitalized tissue and prevent the spreading of infection. The results of the present study suggest that there is no detectable difference between location of central ray amputations and development of re-ulceration, more proximal amputations, or death among this cohort.

      Level of Clinical Evidence

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Foot and Ankle Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weledji E.P.
        • Fokam P.
        Treatment of the diabetic foot – to amputate or not?.
        BMC Surg. 2014; 14: 83https://doi.org/10.1186/1471-2482-14-83
        • Ouzounian Tye J.
        • Shereff Michael J.
        In Vitro Determination of Midfoot Motion.
        Foot & Ankle. 1989; 10: 140-146
        • Schöni M.
        • Waibel F.W.A.
        • Bauer D.
        • et al.
        Long-term results after internal partial forefoot amputation (resection): a retrospective analysis.
        Arch Orthop Trauma Surg. 2020;
        • Armstrong DG
        • Lavery LA
        • Harkless LB
        • Van Houtum WH
        Amputation and reamputation of the diabetic foot.
        J Am Podiatr Med Assoc. 1 June 1997; 87: 255-259
        • Borkosky SL
        • Roukis TS
        Incidence of Re-Amputation Following Partial First Ray Amputation Associated with Diabetes Mellitus and Peripheral Sensory Neuropathy: A Systematic Review.
        Diabetic Foot & Ankle. 2012; 3: 12169
      1. Vadiveloo T, Jeffcoate W, Donnan PT, Colhoun HC, McGur- naghan S, Wild S, McCrimmon R, Leese GP, Scottish Diabetes Research Network Epidemiology G (2018).

        • Amin N
        • Doupis J.
        Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities.
        World J Diabetes. 2016 Apr 10; 7 (PMID: 27076876; PMCID: PMC4824686): 153-164https://doi.org/10.4239/wjd.v7.i7.153
        • Hoffler H.L.
        • Powers N.S.
        • Evans J.K.
        • Blazek C.D.
        Metatarsal Protrusion Distance and Its Influence on Recurrent Ulceration Rates After Partial First-Ray Amputations: A Retrospective Study.
        Journal of the American Podiatric Medical Association. 2022; 112: 20-104
        • Hoffler HL
        • Honeycutt BJ
        • Brackney CK
        • Evans JK
        • Blazek CD
        • Powers NS
        • Burns PR.
        Reulceration and Reoperation Incidence After Isolated Partial Fifth Ray Amputations: A Multicenter Study.
        J Foot Ankle Surg. 2022 Mar-Apr; 61: 298-304https://doi.org/10.1053/j.jfas.2021.08.007
        • Chu YJ
        • Li XW
        • Wang PH
        • Xu J
        • Sun HJ
        • Ding M
        • Jiao J
        • Ji XY
        • Feng SH.
        Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin, China.
        Int Wound J. 2016 Apr; 13: 175-181https://doi.org/10.1111/iwj.122
        • Boffeli TJ
        • Abben KW.
        Complete fifth ray amputation with peroneal tendon transfer–a staged surgical protocol.
        The Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons. 2012 Sep-Oct; 51 (PMID: 22621858): 696-701https://doi.org/10.1053/j.jfas.2012.04.020
        • Clark GD
        • Lui E
        • Cook KD.
        Tendon balancing in pedal amputations.
        Clin Podiatr Med Surg. 2005 Jul; 22 (PMID: 15978411): 447-467https://doi.org/10.1016/j.cpm.2005.03.003
        • Pinzur MS.
        Amputations in the diabetic foot.
        in: Boulton AJM Cavanagh PR Rayman G The Foot in Diabetes. 4th ed. John Wiley & Sons, 2006: 308-322
        • Bevilacqua NJ
        • Rogers LC
        • DellaCorte MP
        • Armstrong DG.
        The narrowed forefoot at 1 year: an advanced approach for wound closure after central ray amputations.
        Clin Podiatr Med Surg. 2008 Jan; 25 (viiiPMID: 18165117): 127-133https://doi.org/10.1016/j.cpm.2007.10.002
        • Sumpio BE.
        Contemporary evaluation and management of the diabetic foot.
        Scientifica (Cairo). 2012; 2012435487https://doi.org/10.6064/2012/435487
        • Thorud JC
        • Jupiter DC
        • Lorenzana J
        • Nguyen TT
        • Shibuya N.
        Reoperation and Reamputation After Transmetatarsal Amputation: A Systematic Review and Meta-Analysis.
        J Foot Ankle Surg. 2016 Sep-Oct; 55: 1007-1012https://doi.org/10.1053/j.jfas.2016.05.011
        • Pollard J
        • Hamilton GA
        • Rush SM
        • Ford LA.
        Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases.
        J Foot Ankle Surg. 2006; 45: 91-97
        • Tokarski AR
        • Barton EC
        • Wagner JT
        • Elliott AD
        • Simonson DC
        • Hordyk PJ
        • Rademaker M.
        Are Transmetatarsal Amputations a Durable Limb Salvage Option? A Single-Institution Descriptive Analysis.
        J Foot Ankle Surg. 2022 May-Jun; 61 (Epub 2021 Oct 21. PMID: 34794876): 537-541https://doi.org/10.1053/j.jfas.2021.10.005
        • Robbins JM
        • Strauss G
        • Aron D
        • Long J
        • Kuba J
        • Kaplan Y
        Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?.
        J Am Podiatr Med Assoc. 2008 Nov-Dec; 98: 489-493
        • Rathnayake A
        • Saboo A
        • Malabu UH
        • Falhammar H.
        Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review.
        World J Diabetes. 2020 Sep 15; 11: 391-399
        • Frykberg RG
        • Zgonis T
        • Armstrong DG
        • Driver VR
        • Giurini JM
        • Kravitz SR
        • Landsman AS
        • Lavery LA
        • Moore JC
        • Schuberth JM
        • Wukich DK
        • Andersen C
        • Vanore JV.
        Diabetic foot disorders: a clinical practice guideline.
        J Foot Ankle Surg. 2006; 45: S1-66